Previous Close | 17.72 |
Open | 17.42 |
Bid | 5.00 x 800 |
Ask | 21.39 x 1000 |
Day's Range | 17.51 - 18.29 |
52 Week Range | 14.04 - 25.63 |
Volume | |
Avg. Volume | 373,147 |
Market Cap | 616.955M |
Beta (5Y Monthly) | 1.06 |
PE Ratio (TTM) | 16.66 |
EPS (TTM) | 1.09 |
Earnings Date | Aug 03, 2022 - Aug 08, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 28.86 |
Subscribe to Yahoo Finance Plus to view Fair Value for COLL
Collegium Pharmaceutical, Inc. ( NASDAQ:COLL ) shareholders might be concerned after seeing the share price drop 17% in...
Large-capitalization stocks have performed better than small-cap stocks over the last year. The overall markets are down 3.7% and core small-caps are down 14%, according to Morningstar.com. So, while momentum investors might choose to buy large-cap stocks for a market recovery, other investors might choose to buy overlooked small-caps that haven’t been bid up. But investors could also consider buying micro-cap stocks for overlooked value. Micro-cap stocks are those with a market capitalizations
STOUGHTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will present at the H.C. Wainwright Global Investment Conference being held at the Fontainebleau Miami Beach Hotel from May 23-26, 2022. Details of the event are as follows:Presentation Date and Time: Tuesday, May 24, 2022, at 3:30 pm ET About Collegium Pharmaceutical, Inc.Collegium is a diversified, specialty p